▲ Peaking
Business
Palantir Estimates Rise as Citi Sees Commercial Growth Rebound
5sources
5articles
3velocity
+0%since first seen
3h agofirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (5)
- Palantir Is Down 25%. Here's Why I'm Buying More. The Motley Fool · 1d ago
- Prediction: 1 Reason Palantir Could Keep Beating the Market 24/7 Wall St. · 1d ago
- Wall Street Analysts Believe Palantir Technologies (PLTR) Could Rally 56.83%: Here's is How to Trade Zacks Investment Research · 1d ago
- Palantir Stock Tumbles Ahead of Earnings. Here's What's Spooking Investors TradingView · 1d ago
- Palantir Estimates Rise as Citi Sees Commercial Growth Rebound Yahoo Finance · 1d ago
Related trends
▲ Peaking
Business
SpaceX at $100 Would Imply Zero AI Value, Morgan Stanley Says
▲ Peaking
Business
Waymo explores split with Uber as robotaxi tensions deepen
▲ Peaking
Business
White House draws new AI line on China
▲ Peaking
Business
FERC will impose reforms if PJM fails to adopt changes by September, chairman warns
▲ Peaking
Business
Some people are getting shut out when it comes to GLP-1 drugs. Here’s why.
Insurance coverage and supply limitations for GLP-1 drugs like Ozempic, Wegovy, and Zepbound are creating a growing divide in patient access.
▲ Peaking
Business